Go Deep
Eurofins Scientific SE
Eurofins Scientific SE Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,060 | 27.2 | 2.95 | 0.96 | 8,353.34 |
| Oct 2026 | 20,004 | 27.4 | 2.97 | 0.96 | 8,405.03 |
| Oct 2026 | 20,010 | 27.4 | 2.98 | 0.96 | 8,411.41 |
| Oct 2026 | 20,026 | 28.1 | 3.05 | 0.96 | 8,591.34 |
| Oct 2026 | 19,906 | 28.9 | 3.14 | 0.96 | 8,835.90 |
Eurofins Scientific SE Quarterly Results
Quarterly data isn't available for this company right now.
Eurofins Scientific SE Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 7,296,100,000.0 | 6,951,000,000.0 | 6,514,600,000.0 | 6,712,100,000.0 | — |
| Net Profit | 474,800,000.0 | 406,400,000.0 | 310,200,000.0 | 610,200,000.0 | — |
| EPS | 2.6 | 2.1 | 1.6 | 3.2 | — |
Eurofins Scientific SE Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 10,985,400,000.0 | 10,888,400,000.0 | 10,888,600,000.0 | 10,083,500,000.0 | — |
| Total Liabilities | 6,408,700,000.0 | 5,503,600,000.0 | 5,751,200,000.0 | 5,232,500,000.0 | — |
| Total Equity | 4,543,300,000.0 | 5,339,000,000.0 | 5,077,500,000.0 | 4,782,100,000.0 | — |
Owes vs Owns
Eurofins Scientific SE owed €0.58 for every €1 it owned in Dec 2025, up from €0.52 in Dec 2022.
| Period | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Owes vs Owns | 0.58× | 0.51× | 0.53× | 0.52× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Eurofins Scientific SE Assets & Liabilities Breakdown (EUR millions)
What it owns — Dec 2025
Cash & short-term investments 7.2%Receivables 10.0%Inventory 1.3%Fixed assets (tangible) 25.2%Intangible assets 48.7%Other assets 7.7%
How it's funded — Dec 2025
Short-term debt 5.4%Long-term debt 31.0%Payables 6.2%Other liabilities 15.8%Shareholders' equity 41.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 791.2 | 613.9 | 1,221.2 | 486.6 |
| Receivables | 1,096.9 | 1,094.4 | 1,072.8 | 1,053.3 |
| Inventory | 139.3 | 141.9 | 139.0 | 145.6 |
| Fixed assets (tangible) | 2,762.9 | 2,559.8 | 2,297.4 | 2,167.7 |
| Intangible assets | 5,347.1 | 5,628.6 | 5,347.4 | 5,443.1 |
| Long-term investments | 5.3 | 5.9 | 5.3 | 5.2 |
| Other assets | 842.7 | 843.9 | 805.5 | 782.0 |
| Liabilities & equity | ||||
| Short-term debt | 588.9 | 328.6 | 458.3 | 85.1 |
| Long-term debt | 3,407.2 | 2,674.2 | 2,889.4 | 2,712.8 |
| Payables | 678.1 | 645.9 | 600.2 | 647.7 |
| Other liabilities | 1,734.5 | 1,854.9 | 1,803.3 | 1,786.9 |
| Shareholders' equity | 4,576.7 | 5,384.8 | 5,137.4 | 4,851.0 |
| Net tangible assets | -803.8 | -289.6 | -269.9 | -661.0 |
Eurofins Scientific SE Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 1,398,900,000.0 | 1,318,900,000.0 | 1,017,900,000.0 | 1,136,300,000.0 | — |
| Investing Activities | -1,076,200,000.0 | -846,500,000.0 | -681,100,000.0 | -855,900,000.0 | — |
| Financing Activities | -101,600,000.0 | -1,089,500,000.0 | 413,600,000.0 | -311,300,000.0 | — |